chrisvoncsefalvay/vaers-outcomes huggingface dataset:
mom noticed fever of 104 @ 1130PM on 30NOV95, was able to bring fever down w/APAP & cold water, pt @ daycare provider;1DEC95 noted to have fever of 101.4, mom picked up pt & noted fever to be 103.5 on 1DEC95 130PM;pt also crying consolably
Information has been received from a nurse concerning a 23 year old female with a penicillin allergy who on 02-APR-2009 was vaccinated with GARDASIL, lot number 661846/1312X. Concomitant therapy included XANAX, LAMICTAL and GEODON. On 01-APR-2009, the nurse reported the patient's blood pressure dropped and her color became pale after a dose of GARDASIL was given. The patient complained of "feeling faint but did not actually faint". The patient sought medical attention she spoke with the nurse. The patient was recovered on 2-APR-2009. No further information was reported. Additional information has been requested.
Faint; Fever; Dizzy; Diarrhea; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in right arm on 20Mar2021 12:00 (Lot Number: EP7534) as single dose for covid-19 immunization at age 76 years old. Not pregnant at the time of vaccination. The patient medical history was not reported. No allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. Concomitant medications included lisinopril; amlodipine besylate; and carvedilol; all taken for product used for unknown indication, start and stop date were not reported. The patient previously received the first dose of BNT162B2 administered in right arm on 26Feb2021 12:00 PM (lot no: EN6202) for COVID-19 immunization at age 76 years old. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 21Mar2021, the patient experienced faint, fever, dizzy, and diarrhea. The events were reported as non-serious. No treatment received for the adverse events. The patient had not recovered from the events.
Neurological symptoms (neuralgia) onset in face after receiving second dose of primary series. After receiving first booster, worsening of neurological symptoms. Parasthesia/neuropathy in hands, feet, face, arms, legs, trunk. Neuralgia. Positive ANA test with speckled pattern 12/2021 (less than one month post booster). Bilateral Trochleitis (inflammation of trochlea tendon/nerve with blurred vision and swelling) onset 2/2021. Muscle weakness upon waking. Joint stiffness. Fatigue. Ongoing and all unresolved.
Lack of sleep; Moderna arm; COVID symptoms; Fatigue; Lymph nodes swelling; This spontaneous case was reported by a nurse and describes the occurrence of INSOMNIA (Lack of sleep), VACCINATION SITE REACTION (Moderna arm), VIRAL INFECTION (COVID symptoms), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025620A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (Lack of sleep), VACCINATION SITE REACTION (Moderna arm), VIRAL INFECTION (COVID symptoms), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swelling). At the time of the report, INSOMNIA (Lack of sleep), VACCINATION SITE REACTION (Moderna arm), VIRAL INFECTION (COVID symptoms), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swelling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided by the reporter.
This spontaneous report was received from a registered nurse and refers to an unspecified amount of unspecified patients of unknown ages and genders. The patients' concurrent conditions and medical history were not provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 injection (lot numbers, expiry dates, doses, route and anatomical sites of injection were not reported). Concomitant therapies were not provided. Information regarding the temperature storage, duration of excursion and previous excursions were not reported. No averse effects were reported. No product quality complain (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Initial report received from a health care professional on 07 November 2013. A 12-year-old patient received FLUZONE HD. (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none
Arm Pain after first shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain after first shot) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain after first shot). At the time of the report, PAIN IN EXTREMITY (Arm Pain after first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs were reported. No treatment drugs are not provided by reporter.
Dizziness, Headache, Myalgia, Arthralgia & NauseaVomiting Narrative:  dose 1-day 2-3-soreness inj site; day 2-3 nausea; aches; dizziness; ha  Other Relevant History:
Three children received a dose of the VARIVAX that was stored out of recommended temperature range.; Information has been received from the office manager and refers to a child patient of unknown age and gender. There was no information about patient's concurrent conditions, medical history, concomitant medications or drug reactions/allergies.  On an unknown date, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (VARIVAX) lot # R035226 and expiration date of 04-DEC-2020 (route of administration and anatomical location were not reported), for prophylaxis, which were stored in the range of 57.9 Fahrenheit degrees for 49 hours. No previous temperature excursion was reported. Unable to retreive the vial as it was disposed of after administration of vaccine.  Digital data logger was involved.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2009USA001660: US-009507513-2009USA001387: US-009507513-2009USA002057:
Hypergammaglobulinemia IgG-2 Subclass Deficiency and Recurrent Infections in Adults. Journal of Allergy Clinical Immunology 2006.Information has been reported in a published abstract, title as stated above concerning four patients in a study (three female (WAES#0602USA05966), one male) between the ages of 51-71 years who were vaccinated with pneumococcal 23v polysaccharide vaccine. All four patients had abnormal responses to pneumococcal 23v polysaccharide vaccine vaccine; one failed to respond to pneumococcal 23v polysaccharide vaccine; one failed to respond to pneumococcal conjugate vaccine as well. There were four patients with hypergammaglobulinemia, IgG 2 subclass deficiency and a history of and/or frequent severe sinopulmonary infections. All four patients had normal responses to tetanus and diphtheria toxoids. Sinusitis was present in all; sinus surgery was required in two out of four patients. There was C4 hypocomplementemia in three out of four patients and autoimmune disease was present in three out of four patients. One patient had chronic lymphocytic leukemia. Two of three patients treated with IGIV had excellent responses. It was reported that the information provided was from the inpatient and outpatient consultation records of a single immunologist over a five year period (2000-2004). Upon review sinusitis was considered to be other medical event (OMIC). No further information is available. A copy of the abstract is attached as further documentation of the patient's experience.
Extreme fatigue, joint and muscle pain.  loss of appetite. generalized weakness and lightheadedness lasting 2-3 days
erectile dysfunction; This spontaneous case was reported by a patient and describes the occurrence of ERECTILE DYSFUNCTION (erectile dysfunction) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021L21A and 041B21A) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On 17-May-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Jan-2022 at 3:45 PM, the patient received third dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced ERECTILE DYSFUNCTION (erectile dysfunction) (seriousness criterion medically significant). At the time of the report, ERECTILE DYSFUNCTION (erectile dysfunction) had not resolved.            No concomitant medication was reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Reportedly, patient started experiencing erectile dysfunction since Pfizer booster. Patient did not have the problem on 04-Jan-2022. As of 31-Mar-2022, patient was still having the same problem which never happened before 04-Jan-2022. Patient did not have COVID related or any health problems. Patient was not tested positive for COVID. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19.  No treatment information was provided.  Device date was reported as 31-Jan-2022.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  Company Comment: This is a Spontaneous case reported by a patient, concerning a 43-year-old male patient, with no medical history reported, who experienced the unexpected and serious (due to medically significant) event of Erectile dysfunction, which occurred 1 day after the third dose of Pfizer vaccine against COVID-19, and after primary vaccination with mRNA-1273 vaccine. No information disclosed about diagnostic tests performed or treatments received. At the time of the report, the event had not resolved. The benefit-risk relationship of mRNA-1273 vaccine, is not affected by this report.; Sender's Comments: This is a Spontaneous case reported by a patient, concerning a 43-year-old male patient, with no medical history reported, who experienced the unexpected and serious (due to medically significant) event of Erectile dysfunction, which occurred 1 day after the third dose of Pfizer vaccine against COVID-19, and after primary vaccination with mRNA-1273 vaccine. No information disclosed about diagnostic tests performed or treatments received. At the time of the report, the event had not resolved. The benefit-risk relationship of mRNA-1273 vaccine, is not affected by this report.
Patient had red area within minute of shot and pain that night. 9/5 the redness was expanding. 9/6 red area was even larger despite ice and Motrin. Went to MD's office where vaccine was administered and he was given Benadryl and a circle was drawn around it.  Tonight, the redness had spread beyond the line and was an area about 6x6 inches.  He came to ER and was diagnosed with possible cellulitis vs vaccine reaction.  He was given Keflex as a discharge Rx.  Only reaction to vaccine was redness.
Right arm began swelling at site of injection 11-02-08 2 days after injection. On 11-03-08 right arm swollen, red and warm to touch with area beginning at injection site ending at the elbow in large oval area.
Headache, Fever, inj arm red/tender, headache, body aches, fever Narrative: Day 1 - headache, body aches; Day 2 -fever took
Pt recvd 1st Hep B vax on 15MAR92 @ approx 445PM & 8PM same day exp abd pain, nausea, diarrhea, vomiting, & a frontal h/a; 16MAR91 & 17MAR91 stated that felt blah on 18MAR91 exp severe abd pain & a fever of 101; pt later recovered;
Woke up in the middle of the night. When I rolled over on my left arm, I was awakened by significant pain. Pain was significant, but subsided when I rolled off it. This morning, I have chills (T 101 F) and flu like aches and pains. My head and body feel exactly like when I've had the flu in the past. My mentation is foggy. I have no drug allergies and no significant PMH. I am a healthcare worker and have been vaccinated against the flu. First dose resulted in arm pain only. Pharmacist told me 2nd dose could have more side effects.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent conditions or medical history were provided. On 29-MAY-2014, the patient was at the pharmacy to receive their third doses of GARDASIL intramuscular injection (dose, route of administration, lot#, expiry date unspecified) and it has been 4 years since the patient's second dose. No concomitant medications or laboratory test were provided. No adverse effects reported. Additional information has been requested.
Flush and feverish (low grade), racing heart. Headache onset at say 6 and continuing.
Severe abdominal cramps shortly after a meal.  Started second day after injection, only once a day in the afternoon or evening shortly after a meal.  Repeated for three days and have been fine for 36 hours now.  No fever, nausea, diarrhea, or constipation.  Cramps lasted about an hour each time and then I felt fine for the rest of the day. I did not see a pattern relating to what I had eaten.
mild muscle weakness; muscle arm soreness; vomiting; chills / chills on and off; extreme weakness all over; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (extreme weakness all over), MUSCULAR WEAKNESS (mild muscle weakness), CHILLS (chills / chills on and off), MYALGIA (muscle arm soreness) and VOMITING (vomiting) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced ASTHENIA (extreme weakness all over) and CHILLS (chills / chills on and off). On an unknown date, the patient experienced MUSCULAR WEAKNESS (mild muscle weakness), MYALGIA (muscle arm soreness) and VOMITING (vomiting). On 14-May-2021, ASTHENIA (extreme weakness all over) outcome was unknown. At the time of the report, MUSCULAR WEAKNESS (mild muscle weakness), CHILLS (chills / chills on and off), MYALGIA (muscle arm soreness) and VOMITING (vomiting) outcome was unknown.            Concomitant medication was not provided.  Treatment information was not provided.   This case was linked to MOD-2021-194112 (Patient Link).
she had a red patch, it swollen with a knots and warm to touch; she had a red patch, it swollen with a knots and warm to touch; Itching at injection site; arm was sore/ it was also hurting at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (she had a red patch, it swollen with a knots and warm to touch), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE PAIN (arm was sore/ it was also hurting at injection site) and VACCINATION SITE ERYTHEMA (she had a red patch, it swollen with a knots and warm to touch) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concomitant products included CEPHALEXIN [CEFALEXIN] for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PAIN (arm was sore/ it was also hurting at injection site). On 12-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at injection site). On 13-Mar-2021, the patient experienced VACCINATION SITE WARMTH (she had a red patch, it swollen with a knots and warm to touch) and VACCINATION SITE ERYTHEMA (she had a red patch, it swollen with a knots and warm to touch). At the time of the report, VACCINATION SITE WARMTH (she had a red patch, it swollen with a knots and warm to touch), VACCINATION SITE PRURITUS (Itching at injection site) and VACCINATION SITE ERYTHEMA (she had a red patch, it swollen with a knots and warm to touch) outcome was unknown and VACCINATION SITE PAIN (arm was sore/ it was also hurting at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant treatment medications were reported.
Right eye tearing and inability to fully close right eye on 2/23/21 progressing to right facial weakness on 2/26/21.  These findings are c/w Bells palsy.  Treated with 10 day course of Prednisone and Refresh tears eye drops
painful right shoulder at injection site; arm hurts, little pain on the R arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurts, little pain on the R arm of injection) and ARTHRALGIA (painful right shoulder at injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007N204) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm hurts, little pain on the R arm of injection). On an unknown date, the patient experienced ARTHRALGIA (painful right shoulder at injection site). At the time of the report, PAIN IN EXTREMITY (arm hurts, little pain on the R arm of injection) had not resolved and ARTHRALGIA (painful right shoulder at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Additional info received  added the event "arthralgia" as per recent followup
Diffuse maculopapular rash from lower legs to upper torso. A few lesions had an urticarial like appearance.
SWELLING AND REDNESS AT INJECTION SITES WITHIN 2 MINUTES OF INJECTIONS, PLUS SWELLING AND REDNESS CIRCUMSCRIBING BOTH ANKLES.  ALSO UNCONSOLLABLE CRYING THAT DECREASED 15 MINUTES AFTER REACTION.  SWELLING PEAKED 2-3 MINUTES AFTER VACCINE ADMINISTRATION, THEN STARTED DECREASING AROUND THE 5-MIN POST VACCINATION PERIOD.  COMPLETELY RESOLVED SWELLING BY 30 MINUTES BUT NO IMPROVEMENT IN CRYING OTHER THAN DURING FORMULA FEEDING AT 15 MINUTE MARK.
10-15-20/  severe pain in left arm suddenly  at 20:00hr; B/ 175/84, hr 51,  lasted most of the night, settled in the morning, this is the pain I had after a day taking my first Levaquin,  These episodes persisted through evening of 10-16;  10/17, until yesterday 10/18, when the pain was less in the evening, heart rate not as high 162/72, alway decreasing after taking my evening heart meds.
This spontaneous report was received from a physician via company representative refers to a female patient of unknown age. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant medications were not reported. On an unknown date in 2015, the patient was vaccinated with GARDASIL (dose, units and frequency not reported) (lot# and expiration date not reported), intramuscularly as middle school vaccine. On an unknown date in 2015, the patient experienced unspecified neurological reaction and was referred to an unspecified neurologist and told that the unspecified neurological reaction (neurological symptom) might have been caused by GARDASIL. The outcome of the event neurological symptom was not reported. The reporter did not provide the causal relationship for the event neurological symptom. No product quality complaint was involved.
Presented to ER on 12/8/21 with 2 days of worsening shortness of breath and cough productive of clear sputum.  The  patient says he was exposed to 2 people who visited him at home, both of whom were having constant cough when they were at his home.  Had some chills at home but  no fever.  Came to emergency room, was found to be quite hypoxemic with a pO2  of only 54 on room air. Patient was placed on 2L HFNC. Started on ceftriaxone, doxy, dexamethasone and remdesivir. Id and pulm consulted. Patient initially on optiflow then weaned down to NC. Completed remdesivir course, sent home to complete steroid course. Patient discharged on  12/14/21 with 4L NC on exertion and 1L NC at rest.
Information has been received from a registered nurse referring to an unknown number of patients of unknown age and gender. No relevant medical history or concurrent conditions were reported. On unknown dates, the patients were vaccinated with GARDASIL (dose and route not reported; lot# and expiration date were unspecified) outside of the recommended dosing schedule. No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
May of 2022- After having COVID in April of 2022, (VAERS report made for COVID after 3rd vaccine).  At the beginning of May, I presented with a cough and nasal drainage.  It got progressively worse, and I contacted my doctor.  On 5/12/22 I had a telehealth and diagnosed with bacteria bronchitis.  I was put on Doxycycline for 7 days, Codeine Cough syrup and Ibuprofen. On 5/24/22 I had a telehealth and diagnosed with a sinus infection and still had the bacteria bronchitis. I was started on Amoxicillin for 7 days.  I went to the doctor on 11/28/22 for a sinus infection and bronchitis.  I had a swollen gland on my left jaw. I was given benzonatate for cough. I had a chest x-ray which was normal, no pneumonia.  Two weeks ago, I got Bronchitis again. I used the benzonatate I had left over and took Mucinex, Dayquil and Nyquil.   I did not call the doctor. I continue to have a lingering cough.  I have bouts of Bronchitis since May of 22 , about every two months, but do not go to the doctor every time. I am a former smoker.
This is in follow-up to report (s) submitted on 8/14/2007. Information has been received from a physician concerning a 2 month old female with pertinent medical history and drug reactions/allergies reported as non who on 11-JUN-2007 was vaccinated with ROTATEQ a first dose (lot #656835/0624U), oral. Concomitant medication was reported as none. In approximately June 2007, several weeks post vaccination, the patient experienced stools that were looser than normal. No other symptoms were noted. The patient sought unspecified medical attention. The outcome and causality of the event were not reported. No product quality complaint was involved. Additional information has been requested.
Headache, Fever, Chills, fatigue Narrative:  Other Relevant History: